Daehwa Lozartan Plus F Tablets

Adult dose

The usual dose of this medication is one tablet containing 50 mg of losartan potassium/12.5 mg of hydrochlorothiazide taken once daily. Doses exceeding 100 mg of losartan potassium/25 mg of hydrochlorothiazide per day are not advisable. Start with one tablet containing 50 mg of losartan potassium/12.5 mg of hydrochlorothiazide once daily, and if blood pressure remains uncontrolled after 3 weeks, the dose may be increased to a maximum of losartan potassium 100 mg/25 mg of hydrochlorothiazide once daily.

Child dose

There is no experience in using this medication in children and adolescents, so the losartan-hydrochlorothiazide combination should not be administered to children and adolescents.

This medication can cause serious harm, particularly to the fetus, if taken during pregnancy; therefore, it should not be used by women who are pregnant or may become pregnant. Patients who are allergic to this medication or have severely impaired kidney function, severely damaged liver function, or specific electrolyte imbalances should avoid using it. Patients with hypotension, kidney problems, liver disease, etc., require special caution when using this medication and should take it carefully as directed by a physician. This medication lowers blood pressure, and dizziness or drowsiness may occur during use, so caution is needed when driving or operating machinery. While taking this medication, renal function and electrolyte levels should be regularly monitored through blood tests, and care should be taken to prevent potassium levels from becoming too high or too low. This medication may interact with other antihypertensive medications, diuretics, and potassium supplements; therefore, if other medications are being taken, it is essential to inform the physician or pharmacist. The hydrochlorothiazide component may cause increased skin sensitivity to sunlight; thus, sun exposure should be avoided and skin protection should be ensured. If unusual symptoms or allergic reactions occur during use, medical consultation should be sought immediately, especially if swelling of the face, lips, or throat occurs, indicating a need for urgent treatment. It is not used in children or adolescents as safety and efficacy have not been established. Elderly patients may experience more frequent adverse reactions and require more caution when taking this medication. This medication should be taken strictly according to the prescribed dosage and administration and should not be stopped or altered without physician consent.

Serious side effects

Hives, severe swelling (edema), difficulty breathing, angioedema (may cause airway obstruction due to laryngeal/glottic swelling, swelling of the face/lips/pharynx/tongue), severe allergic reactions, skin peeling, pain in oral/ocular mucosa, severe skin reactions, shortness of breath or difficulty breathing, asthma attacks, respiratory issues accompanied by cough and fever, yellowing of skin or eyes (jaundice), extreme lethargy, liver abnormalities (jaundice),

Mild side effects

Abdominal pain, swelling, palpitations, back pain, dizziness, cough, sinusitis, upper respiratory infection, weakness/fatigue, diarrhea, nausea, headache, bronchitis, pharyngitis, angioedema (swelling of lips and eyelids and facial rash), chest pain, facial swelling, fever, orthostatic hypotension, syncope, angina, arrhythmias (atrial fibrillation, sinus bradycardia, tachycardia, ventricular tachycardia, ventricular fibrillation), hypotension, myocardial infarction, secondary atrioventricular block, decreased appetite, constipation, dental pain, flatulence

This medication is sensitive to light and should be stored in a tightly sealed container that prevents light exposure. It is important to maintain a storage temperature between 1 to 30 degrees Celsius to ensure the effectiveness and safety of the medication.

Appearance

Pale yellow oval film-coated tablet

Package unit

10 tablets/blister x 3, 300 tablets/bottle